papillary thyroid cancer glp-1 Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study Glucagon-like peptide-1 medicines and cancer
Description
A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimers disease, slowing cognitive decline by 18% over one year.
A recent study links use of weight-loss drugs like Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound to vision loss in patients.
Objective This systematic review aims to synthesise published evidence on respiratory adverse events temporally associated with GLP-1 RA therapy in adults, characterise their patterns and severity, appraise the risk of bias using validated design-appropriate tools, describe proposed pathophysiological mechanisms, and grade the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework
Learn how it works, whos eligible, what results to expect, and key things to know before starting treatment.
On average, workers contribute $6,850 annually to the cost of family coverage, with employers paying the rest.
Stopping GLP-1 medications like semaglutide before surgery requires careful timing coordinated with your surgical team
